Melatonin: Some Aspects of Biochemistry, Physiology, and Pharmacology.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human experimental data
PubMed 42115453 · doi:10.1007/978-3-032-18608-9_4
What was done
This is a narrative review outlining the biochemistry, physiological regulation, and pharmacological properties of melatonin, including its synthesis pathway from tryptophan, regulation by the suprachiasmatic nucleus (SCN), and role in modulating circadian rhythmicity.
What was found
The abstract reports no numerical data or statistical metrics. It describes qualitatively that melatonin is synthesized in the pineal gland, peaks endogenously around 3 a.m. depending on chronotype, acts as an endogenous synchronizer of central and peripheral clocks, and exhibits chronobiotic activity capable of phase-advancing or phase-delaying circadian rhythms depending on administration timing for disorders such as jet lag, delayed-sleep phase syndrome, and non-24-hour sleep disorder.
Why it matters
It clarifies that melatonin acts primarily as an endogenous darkness messenger and circadian synchronizer rather than a classic sedative, establishing the physiological rationale for timed exogenous dosing in circadian dysrhythmias.
Limits
This is an unstructured narrative review without systematic search methods, primary data, sample sizes, or quantitative outcome measures. Dosing protocols, precise timing windows, efficacy magnitudes, and potential adverse effects are not detailed in the abstract.
Cited by
- supports Melatonin is released from the pineal gland.